PRESS RELEASE published on 10/31/2023 at 07:00, 2 years 6 months ago PolyPeptide signs scientific collaboration agreement
PRESS RELEASE published on 10/02/2023 at 07:00, 2 years 7 months ago PolyPeptide secures revolving credit facility
PRESS RELEASE published on 08/15/2023 at 07:00, 2 years 8 months ago Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO
PRESS RELEASE published on 07/13/2023 at 07:00, 2 years 9 months ago PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023
PRESS RELEASE published on 05/09/2023 at 20:40, 2 years 11 months ago PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
PRESS RELEASE published on 04/12/2023 at 19:18, 3 years ago PolyPeptide announces results of the annual General Meeting 2023
PRESS RELEASE published on 04/03/2023 at 07:00, 3 years 1 month ago PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO
PRESS RELEASE published on 03/22/2023 at 07:00, 3 years 1 month ago PolyPeptide publishes invitation to the annual General Meeting 2023
Published on 05/06/2026 at 02:17, 32 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 49 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 01:20, 1 hour 29 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 01:35, 1 hour 14 minutes ago VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Published on 05/06/2026 at 00:05, 2 hours 44 minutes ago ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds
Published on 05/05/2026 at 23:05, 3 hours 44 minutes ago Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Published on 05/05/2026 at 22:07, 4 hours 42 minutes ago Kaufman & Broad SA: MISE EN PAIEMENT DU DIVIDENDE AU TITRE DE L’EXERCICE CLOS LE 30 NOVEMBRE 2025
Published on 05/05/2026 at 22:07, 4 hours 42 minutes ago Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2025
Published on 05/05/2026 at 19:00, 7 hours 49 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 7 hours 49 minutes ago Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 8 hours 9 minutes ago Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 8 hours 46 minutes ago Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026
